Article
Eribulin inhibits tumor growth of two novel patient-derived xenograft models of Merkel cell carcinoma
2024-08-13
Abstract excerpt
<title>Abstract</title> <p>Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer with a poor prognosis in advanced cases. While MCC has been reported to be sensitive to chemotherapy and immunotherapy, only about 50% of tumors respond to these treatments. Although developing novel therapeutic strategies against MCC has been desired, few preclinical models, including cell lines and patient-de...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 82f9b901-baa0-57c5-b59e-a8e2f42cdf33
- DOI
- 10.21203/rs.3.rs-4728513/v1
